BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaelin WG. The emerging p53 gene family. J Natl Cancer Inst. 1999;91:594-598. [PMID: 10203277 DOI: 10.1093/jnci/91.7.594] [Cited by in Crossref: 95] [Cited by in F6Publishing: 98] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Zhang S, Chen H, Yue D, Blackwell TS, Lv C, Song X. Long non-coding RNAs: Promising new targets in pulmonary fibrosis. J Gene Med 2021;23:e3318. [PMID: 33533071 DOI: 10.1002/jgm.3318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhang Y, Li C, Sun S, Cao Z, Chen J, Xiang H, Song L. Screening and Identification of Molecular Targets Involved in Preventing Gastric Precancerous Lesions in Chronic Atrophic Gastritis by Qilianshupi Decoction. Evid Based Complement Alternat Med 2019;2019:5804710. [PMID: 31929816 DOI: 10.1155/2019/5804710] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Du Y, Hao X, Liu X. Low expression of long noncoding RNA CDKN2B-AS1 in patients with idiopathic pulmonary fibrosis predicts lung cancer by regulating the p53-signaling pathway. Oncol Lett 2018;15:4912-8. [PMID: 29541247 DOI: 10.3892/ol.2018.7910] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
4 Liang S, Gong X, Zhang G, Huang G, Lu Y, Li Y. The lncRNA XIST interacts with miR-140/miR-124/iASPP axis to promote pancreatic carcinoma growth. Oncotarget 2017;8:113701-18. [PMID: 29371940 DOI: 10.18632/oncotarget.22555] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
5 El-Dahr SS, Li Y, Liu J, Gutierrez E, Hering-Smith KS, Signoretti S, Pignon JC, Sinha S, Saifudeen Z. p63+ ureteric bud tip cells are progenitors of intercalated cells. JCI Insight 2017;2:89996. [PMID: 28469077 DOI: 10.1172/jci.insight.89996] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
6 Owosho AA, Aguilar CE, Seethala RR. Comparison of p63 and p40 (ΔNp63) as Basal, Squamoid, and Myoepithelial Markers in Salivary Gland Tumors. Applied Immunohistochemistry & Molecular Morphology 2016;24:501-8. [DOI: 10.1097/pai.0000000000000222] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
7 Gama A, Alves A, Gartner F, Schmitt F. p63: A Novel Myoepithelial Cell Marker in Canine Mammary Tissues. Vet Pathol 2003;40:412-20. [DOI: 10.1354/vp.40-4-412] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 11.0] [Reference Citation Analysis]
8 Ferraiuolo M, Di Agostino S, Blandino G, Strano S. Oncogenic Intra-p53 Family Member Interactions in Human Cancers. Front Oncol. 2016;6:77. [PMID: 27066457 DOI: 10.3389/fonc.2016.00077] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 7.2] [Reference Citation Analysis]
9 Neumann S, El Maadidi S, Faletti L, Haun F, Labib S, Schejtman A, Maurer U, Borner C. How do viruses control mitochondria-mediated apoptosis? Virus Res 2015;209:45-55. [PMID: 25736565 DOI: 10.1016/j.virusres.2015.02.026] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
10 Pappano WN, Zhang Q, Tucker LA, Tse C, Wang J. Genetic inhibition of the atypical kinase Wee1 selectively drives apoptosis of p53 inactive tumor cells. BMC Cancer. 2014;14:430. [PMID: 24927813 DOI: 10.1186/1471-2407-14-430] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
11 Newton HB. Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors Part 4: p53 signaling pathway. Expert Review of Anticancer Therapy 2014;5:177-91. [DOI: 10.1586/14737140.5.1.177] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
12 Senoo M. Epidermal Stem Cells in Homeostasis and Wound Repair of the Skin. Adv Wound Care (New Rochelle) 2013;2:273-82. [PMID: 24527349 DOI: 10.1089/wound.2012.0372] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
13 Abe S, Kurata M, Suzuki S, Yamamoto K, Aisaki K, Kanno J, Kitagawa M. Minichromosome maintenance 2 bound with retroviral Gp70 is localized to cytoplasm and enhances DNA-damage-induced apoptosis. PLoS One 2012;7:e40129. [PMID: 22768239 DOI: 10.1371/journal.pone.0040129] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
14 van Bergeijk P, Heimiller J, Uyetake L, Su TT. Genome-wide expression analysis identifies a modulator of ionizing radiation-induced p53-independent apoptosis in Drosophila melanogaster. PLoS One 2012;7:e36539. [PMID: 22666323 DOI: 10.1371/journal.pone.0036539] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
15 Hu Y, Jiang L, Zheng J, You Y, Zhou Y, Jiao S. Association between the p73 exon 2 G4C14-to-A4T14 polymorphism and cancer risk: a meta-analysis. DNA Cell Biol 2012;31:230-7. [PMID: 22011187 DOI: 10.1089/dna.2011.1305] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
16 Donzelli S, Biagioni F, Fausti F, Strano S, Fontemaggi G, Blandino G. Oncogenomic Approaches in Exploring Gain of Function of Mutant p53. Curr Genomics 2008;9:200-7. [PMID: 19440517 DOI: 10.2174/138920208784340713] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
17 Kresty LA, Howell AB, Baird M. Cranberry proanthocyanidins mediate growth arrest of lung cancer cells through modulation of gene expression and rapid induction of apoptosis. Molecules 2011;16:2375-90. [PMID: 21399574 DOI: 10.3390/molecules16032375] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
18 Liu W, Li X, Chu ES, Go MY, Xu L, Zhao G, Li L, Dai N, Si J, Tao Q, Sung JJ, Yu J. Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway. Hepatology 2011;53:843-53. [PMID: 21319196 DOI: 10.1002/hep.24124] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 4.6] [Reference Citation Analysis]
19 Zhang W, Zhu J, Bai J, Jiang H, Liu F, Liu A, Liu P, Ji G, Guan R, Sun D, Ji W, Yu Y, Jin Y, Meng X, Fu S. Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549. J Exp Clin Cancer Res 2010;29:74. [PMID: 20565749 DOI: 10.1186/1756-9966-29-74] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
20 Chatterjee A, Chang X, Sen T, Ravi R, Bedi A, Sidransky D. Regulation of p53 family member isoform DeltaNp63alpha by the nuclear factor-kappaB targeting kinase IkappaB kinase beta. Cancer Res 2010;70:1419-29. [PMID: 20145131 DOI: 10.1158/0008-5472.CAN-09-2613] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
21 Clements S, Techanukul T, Coman D, Mellerio J, Mcgrath J. Molecular basis of EEC (ectrodactyly, ectodermal dysplasia, clefting) syndrome: five new mutations in the DNA-binding domain of the TP63 gene and genotype-phenotype correlation: Molecular basis of EEC syndrome. British Journal of Dermatology 2010;162:201-7. [DOI: 10.1111/j.1365-2133.2009.09496.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
22 Saxena N, Ansari KM, Kumar R, Dhawan A, Dwivedi PD, Das M. Patulin causes DNA damage leading to cell cycle arrest and apoptosis through modulation of Bax, p53 and p21/WAF1 proteins in skin of mice. Toxicology and Applied Pharmacology 2009;234:192-201. [DOI: 10.1016/j.taap.2008.09.033] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
23 Jang S, Kim J, Choi K. p19 ras Accelerates p73β‐mediated apoptosis through a caspase‐3 dependent pathway. Animal Cells and Systems 2009;13:399-403. [DOI: 10.1080/19768354.2009.9647235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Strano S, Dell'Orso S, Di Agostino S, Fontemaggi G, Sacchi A, Blandino G. Mutant p53: an oncogenic transcription factor. Oncogene. 2007;26:2212-2219. [PMID: 17401430 DOI: 10.1038/sj.onc.1210296] [Cited by in Crossref: 176] [Cited by in F6Publishing: 163] [Article Influence: 11.7] [Reference Citation Analysis]
25 Choi JE, Kang HG, Chae MH, Kim EJ, Lee WK, Cha SI, Kim CH, Jung TH, Park JY. No association between p73 G4C14-to-A4T14 polymorphism and the risk of lung cancer in a Korean population. Biochem Genet 2006;44:543-50. [PMID: 17136456 DOI: 10.1007/s10528-006-9056-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
26 Jun HJ, Park SH, Lee WK, Choi JE, Jang JS, Kim EJ, Cha SI, Kim DS, Kam S, Kim CH, Kang YM, Jung TH, Park JY. Combined effects of p73 and MDM2 polymorphisms on the risk of lung cancer. Mol Carcinog 2007;46:100-5. [PMID: 17013834 DOI: 10.1002/mc.20279] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
27 Maluf F, Cordon-cardo C, Verbel D, Satagopan J, Boyle M, Herr H, Bajorin D. Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment. Annals of Oncology 2006;17:1677-86. [DOI: 10.1093/annonc/mdl289] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
28 Ram R, Uziel O, Lahav M. The importance of the telomere and telomerase system in hematological malignancies. Leuk Lymphoma 2005;46:1121-35. [PMID: 16085552 DOI: 10.1080/10428190500125853] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
29 Pérez LO, Abba MC, Dulout FN, Golijow CD. Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina. World J Gastroenterol 2006; 12(9): 1426-1429 [PMID: 16552814 DOI: 10.3748/wjg.v12.i9.1426] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
30 Jeong MH, Bae J, Kim WH, Yoo SM, Kim JW, Song PI, Choi KH. p19ras interacts with and activates p73 by involving the MDM2 protein. J Biol Chem 2006;281:8707-15. [PMID: 16436381 DOI: 10.1074/jbc.M513853200] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
31 Saifudeen Z, Diavolitsis V, Stefkova J, Dipp S, Fan H, El-dahr SS. Spatiotemporal Switch from ΔNp73 to TAp73 Isoforms during Nephrogenesis. Journal of Biological Chemistry 2005;280:23094-102. [DOI: 10.1074/jbc.m414575200] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
32 Seethala RR, Livolsi VA, Zhang PJ, Pasha TL, Baloch ZW. Comparison of p63 and p73 expression in benign and malignant salivary gland lesions. Head Neck 2005;27:696-702. [DOI: 10.1002/hed.20227] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
33 Blundell R, Kaminski N, Harrison D. Increase in p21 expression independent of the p53 pathway in bleomycin-induced lung fibrosis. Exp Mol Pathol 2004;77:231-7. [PMID: 15507241 DOI: 10.1016/j.yexmp.2004.07.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
34 Kamiya M, Takeuchi Y, Katho M, Yokoo H, Sasaki A, Nakazato Y. Expression of p73 in normal skin and proliferative skin lesions. Pathol Int 2004;54:890-5. [DOI: 10.1111/j.1440-1827.2004.01777.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
35 Chen YK, Huse SS, Lin LM. Differential expression of p53, p63 and p73 protein and mRNA for DMBA-induced hamster buccal-pouch squamous-cell carcinomas. Int J Exp Pathol 2004;85:97-104. [PMID: 15154915 DOI: 10.1111/j.0959-9673.2004.0374.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
36 Tudzarova-Trajkovska S, Wesierska-Gadek J. Strong induction of p73 protein in vivo coincides with the onset of apoptosis in rat liver after treatment with the hepatocarcinogen N-nitrosomorpholine (NNM). J Cell Biochem. 2003;90:837-855. [PMID: 14587038 DOI: 10.1002/jcb.10678] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
37 Chen Y, Hsue S, Lin L. Expression of p63 (TA and ▴N isoforms) in human primary well differentiated buccal carcinomas. International Journal of Oral and Maxillofacial Surgery 2004;33:493-7. [DOI: 10.1016/j.ijom.2003.10.023] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
38 Polychronopoulou S, Koutroumba P. Telomere Length and Telomerase Activity: Variations With Advancing Age and Potential Role in Childhood Malignancies: . Journal of Pediatric Hematology/Oncology 2004;26:342-50. [DOI: 10.1097/00043426-200406000-00003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
39 Huang XE, Hamajima N, Katsuda N, Matsuo K, Hirose K, Mizutani M, Iwata H, Miura S, Xiang J, Tokudome S, Tajima K. Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer. Breast Cancer 2003;10:307-11. [PMID: 14634508 DOI: 10.1007/BF02967650] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 3.6] [Reference Citation Analysis]
40 Chen YK, Huse SS, Lin LM. Differential expression of p53, p63 and p73 proteins in human buccal squamous-cell carcinomas. Clin Otolaryngol Allied Sci. 2003;28:451-455. [PMID: 12969350 DOI: 10.1046/j.1365-2273.2003.00743.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
41 Marchbank A, Su LJ, Walsh P, DeGregori J, Penheiter K, Grayson TB, Dellavalle RP, Lee LA. The CUSP DeltaNp63alpha isoform of human p63 is downregulated by solar-simulated ultraviolet radiation. J Dermatol Sci 2003;32:71-4. [PMID: 12788532 DOI: 10.1016/s0923-1811(03)00040-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
42 Sakoonwatanyoo P, Tan DT, Smith DR. Expression of p63 in Pterygium and Normal Conjunctiva: . Cornea 2004;23:67-70. [DOI: 10.1097/00003226-200401000-00011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
43 Lechpammer M, Lukac J, Lechpammer S, Kovacević D, Loda M, Kusić Z. Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy. Int J Colorectal Dis 2004;19:114-20. [PMID: 14634775 DOI: 10.1007/s00384-003-0553-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
44 Monti P, Campomenosi P, Ciribilli Y, Iannone R, Aprile A, Inga A, Tada M, Menichini P, Abbondandolo A, Fronza G. Characterization of the p53 mutants ability to inhibit p73 beta transactivation using a yeast-based functional assay. Oncogene. 2003;22:5252-5260. [PMID: 12917626 DOI: 10.1038/sj.onc.1206511] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
45 Lavia P, Mileo AM, Giordano A, Paggi MG. Emerging roles of DNA tumor viruses in cell proliferation: new insights into genomic instability. Oncogene 2003;22:6508-16. [DOI: 10.1038/sj.onc.1206861] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 2.5] [Reference Citation Analysis]
46 Chen Y, Hsue S, Lin L. Immunohistochemical demonstration of p63 in DMBA-induced hamster buccal pouch squamous cell carcinogenesis: p63 in DMBA-carcinogenesis. Oral Diseases 2003;9:235-40. [DOI: 10.1034/j.1601-0825.2003.02920.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
47 Wang LD, Zheng S, Zheng ZY, Casson AG. Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J Gastroenterol 2003; 9(6): 1156-1164 [PMID: 12800215 DOI: 10.3748/wjg.v9.i6.1156] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.0] [Reference Citation Analysis]
48 Wang X, Mori I, Tang W, Nakamura M, Nakamura Y, Sato M, Sakurai T, Kakudo K. p63 expression in normal, hyperplastic and malignant breast tissues. Breast Cancer 2002;9:216-9. [PMID: 12185332 DOI: 10.1007/BF02967592] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 2.8] [Reference Citation Analysis]
49 Guo SS, Arora C, Shimoide AT, Sawicki MP. Frequent deletion of chromosome 3 in malignant sporadic pancreatic endocrine tumors. Mol Cell Endocrinol 2002;190:109-14. [PMID: 11997184 DOI: 10.1016/s0303-7207(02)00002-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
50 Liu G, Chen X. The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis. Oncogene 2002;21:7195-204. [DOI: 10.1038/sj.onc.1205862] [Cited by in Crossref: 120] [Cited by in F6Publishing: 128] [Article Influence: 6.0] [Reference Citation Analysis]
51 Reis-Filho JS, Schmitt FC. Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker. Adv Anat Pathol 2002;9:280-9. [PMID: 12195217 DOI: 10.1097/00125480-200209000-00002] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 3.8] [Reference Citation Analysis]
52 Lumachi F, Basso S. Apoptosis: life through planned cellular death regulating mechanisms, control systems, and relations with thyroid diseases. Thyroid 2002;12:27-34. [PMID: 11838727 DOI: 10.1089/105072502753451931] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
53 Mcgregor JM, Harwood CA, Brooks L, Kelly DA, O’nions J, Young AR, Surentheran T, Breuer J, Millard TP, Lewis CM, Leigh IM, Storey A, Crook T, Fisher SA. Relationship Between p53 Codon 72 Polymorphism and Susceptibility to Sunburn and Skin Cancer. Journal of Investigative Dermatology 2002;119:84-90. [DOI: 10.1046/j.1523-1747.2002.01655.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 302] [Article Influence: 3.1] [Reference Citation Analysis]
54 Kang K, Lee J, Kim K, Ham S, Kim M, Choi KH. Induction of p73β by a naphthoquinone analog is mediated by E2F-1 and triggers apoptosis in HeLa cells. FEBS Letters 2002;522:161-7. [DOI: 10.1016/s0014-5793(02)02921-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
55 Chen CJ, Tsai NM, Liu YC, Ho LI, Hsieh HF, Yen CY, Harn HJ. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression. Eur J Surg Oncol. 2002;28:225-234. [PMID: 11944954 DOI: 10.1053/ejso.2001.1237] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
56 Nikitina EY, Chada S, Muro-Cacho C, Fang B, Zhang R, Roth JA, Gabrilovich DI. An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53. Gene Ther 2002;9:345-52. [PMID: 11938454 DOI: 10.1038/sj.gt.3301670] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
57 Strano S, Fontemaggi G, Costanzo A, Rizzo MG, Monti O, Baccarini A, Del Sal G, Levrero M, Sacchi A, Oren M, Blandino G. Physical interaction with human tumor-derived p53 mutants inhibits p63 activities. J Biol Chem 2002;277:18817-26. [PMID: 11893750 DOI: 10.1074/jbc.M201405200] [Cited by in Crossref: 159] [Cited by in F6Publishing: 157] [Article Influence: 8.0] [Reference Citation Analysis]
58 Nozell S, Chen X. p21B, a variant of p21(Waf1/Cip1), is induced by the p53 family. Oncogene 2002;21:1285-94. [PMID: 11850848 DOI: 10.1038/sj.onc.1205191] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 2.5] [Reference Citation Analysis]
59 Helder MN, Wisman GB, van der Zee GJ. Telomerase and telomeres: from basic biology to cancer treatment. Cancer Invest 2002;20:82-101. [PMID: 11855380 DOI: 10.1081/cnv-120000370] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
60 Pelosi G, Pasini F, Olsen Stenholm C, Pastorino U, Maisonneuve P, Sonzogni A, Maffini F, Pruneri G, Fraggetta F, Cavallon A, Roz E, Iannucci A, Bresaola E, Viale G. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas? J Pathol 2002;198:100-9. [DOI: 10.1002/path.1166] [Cited by in Crossref: 110] [Cited by in F6Publishing: 101] [Article Influence: 5.5] [Reference Citation Analysis]
61 Stros M, Ozaki T, Bacikova A, Kageyama H, Nakagawara A. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter. J Biol Chem 2002;277:7157-64. [PMID: 11748232 DOI: 10.1074/jbc.M110233200] [Cited by in Crossref: 129] [Cited by in F6Publishing: 129] [Article Influence: 6.1] [Reference Citation Analysis]
62 Vikhanskaya F, Bani MR, Borsotti P, Ghilardi C, Ceruti R, Ghisleni G, Marabese M, Giavazzi R, Broggini M, Taraboletti G. p73 overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis. Oncogene 2001;20:7293-300. [DOI: 10.1038/sj.onc.1204896] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 1.9] [Reference Citation Analysis]
63 Yamaguchi H, Inokuchi K, Sakuma Y, Dan K. Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia. Leukemia 2001;15:1729-34. [DOI: 10.1038/sj.leu.2402265] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
64 Faridoni-Laurens L, Bosq J, Janot F, Vayssade M, Le Bihan ML, Kaghad M, Caput D, Bénard J, Ahomadegbe JC. P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63? Oncogene 2001;20:5302-12. [PMID: 11536043 DOI: 10.1038/sj.onc.1204687] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
65 Zhu J, Nozell S, Wang J, Jiang J, Zhou W, Chen X. p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner. Oncogene 2001;20:4050-7. [PMID: 11494133 DOI: 10.1038/sj.onc.1204516] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
66 Ponz de Leon M, Percesepe A. Pathogenesis of colorectal cancer. Dig Liver Dis. 2000;32:807-821. [PMID: 11215564 DOI: 10.1016/s1590-8658(00)80361-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
67 Barbareschi M, Pecciarini L, Cangi MG, Macrì E, Rizzo A, Viale G, Doglioni C. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 2001;25:1054-60. [PMID: 11474290 DOI: 10.1097/00000478-200108000-00010] [Cited by in Crossref: 260] [Cited by in F6Publishing: 237] [Article Influence: 12.4] [Reference Citation Analysis]
68 Orlando C, Gelmini S, Selli C, Pazzagli M. TELOMERASE IN UROLOGICAL MALIGNANCY. Journal of Urology 2001;166:666-73. [DOI: 10.1016/s0022-5347(05)66040-5] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
69 Dohn M, Zhang S, Chen X. p63α and ΔNp63α can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene 2001;20:3193-205. [DOI: 10.1038/sj.onc.1204427] [Cited by in Crossref: 191] [Cited by in F6Publishing: 203] [Article Influence: 9.1] [Reference Citation Analysis]
70 Senoo M, Tsuchiya I, Matsumura Y, Mori T, Saito Y, Kato H, Okamoto T, Habu S. Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Delta Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51. Br J Cancer 2001;84:1235-41. [PMID: 11336476 DOI: 10.1054/bjoc.2000.1735] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 1.9] [Reference Citation Analysis]
71 Szak ST, Mays D, Pietenpol JA. Kinetics of p53 binding to promoter sites in vivo. Mol Cell Biol 2001;21:3375-86. [PMID: 11313463 DOI: 10.1128/MCB.21.10.3375-3386.2001] [Cited by in Crossref: 126] [Cited by in F6Publishing: 131] [Article Influence: 6.0] [Reference Citation Analysis]
72 Strano S, Rossi M, Fontemaggi G, Munarriz E, Soddu S, Sacchi A, Blandino G. From p63 to p53 across p73. FEBS Lett 2001;490:163-70. [PMID: 11223031 DOI: 10.1016/s0014-5793(01)02119-6] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 3.1] [Reference Citation Analysis]
73 Tan M, Bian J, Guan K, Sun Y. p53CP is p51/p63, the third member of the p53 gene family: partial purification and characterization. Carcinogenesis 2001;22:295-300. [PMID: 11181451 DOI: 10.1093/carcin/22.2.295] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
74 Kobayashi N, Takada Y, Hachiya M, Ando K, Nakajima N, Akashi M. TNF-alpha induced p21(WAF1) but not Bax in colon cancer cells WiDr with mutated p53: important role of protein stabilization. Cytokine 2000;12:1745-54. [PMID: 11097743 DOI: 10.1006/cyto.2000.0782] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
75 Porrello A, Cerone MA, Coen S, Gurtner A, Fontemaggi G, Cimino L, Piaggio G, Sacchi A, Soddu S. p53 regulates myogenesis by triggering the differentiation activity of pRb. J Cell Biol 2000;151:1295-304. [PMID: 11121443 DOI: 10.1083/jcb.151.6.1295] [Cited by in Crossref: 87] [Cited by in F6Publishing: 90] [Article Influence: 4.1] [Reference Citation Analysis]
76 Takahashi H, Fukutome K, Watanabe M, Furusato M, Shiraishi T, Ito H, Suzuki H, Ikawa S, Hano H. Mutation analysis of thep51 gene and correlation betweenp53,p73, andp51 expressions in prostatic carcinoma. Prostate 2001;47:85-90. [DOI: 10.1002/pros.1050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
77 Murphy KL, Dennis AP, Rosen JM. A gain of function p53 mutant promotes both genomic instability and cell survival in a novel p53-null mammary epithelial cell model. FASEB J 2000;14:2291-302. [PMID: 11053251 DOI: 10.1096/fj.00-0128com] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 2.9] [Reference Citation Analysis]
78 Strano S, Munarriz E, Rossi M, Cristofanelli B, Shaul Y, Castagnoli L, Levine AJ, Sacchi A, Cesareni G, Oren M. Physical and functional interaction between p53 mutants and different isoforms of p73. J Biol Chem. 2000;275:29503-29512. [PMID: 10884390 DOI: 10.1074/jbc.m003360200] [Cited by in Crossref: 166] [Cited by in F6Publishing: 166] [Article Influence: 7.5] [Reference Citation Analysis]
79 Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W, Flores ER, Tsai KY, Jacks T, Vousden KH. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature. 2000;407:645-648. [PMID: 11034215 DOI: 10.1038/35036614] [Cited by in Crossref: 393] [Cited by in F6Publishing: 415] [Article Influence: 17.9] [Reference Citation Analysis]
80 Ahmad N, Cheng P, Mukhtar H. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Biochem Biophys Res Commun. 2000;275:328-334. [PMID: 10964666 DOI: 10.1006/bbrc.2000.3297] [Cited by in Crossref: 166] [Cited by in F6Publishing: 146] [Article Influence: 7.5] [Reference Citation Analysis]
81 O'Hare MJ, Hou ST, Morris EJ, Cregan SP, Xu Q, Slack RS, Park DS. Induction and modulation of cerebellar granule neuron death by E2F-1. J Biol Chem 2000;275:25358-64. [PMID: 10851232 DOI: 10.1074/jbc.M001725200] [Cited by in Crossref: 99] [Cited by in F6Publishing: 106] [Article Influence: 4.5] [Reference Citation Analysis]
82 Banelli B, Casciano I, Romani M. Methylation-independent silencing of the p73 gene in neuroblastoma. Oncogene 2000;19:4553-6. [DOI: 10.1038/sj.onc.1203807] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
83 Soussi T. The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann N Y Acad Sci. 2000;910:121-137; discussion 137-139. [PMID: 10911910 DOI: 10.1111/j.1749-6632.2000.tb06705.x] [Cited by in Crossref: 177] [Cited by in F6Publishing: 186] [Article Influence: 8.0] [Reference Citation Analysis]
84 Ichimiya S, Nakagawara A, Sakuma Y, Kimura S, Ikeda T, Satoh M, Takahashi N, Sato N, Mori M. p73: Structure and function. Pathol Int 2000;50:589-93. [DOI: 10.1046/j.1440-1827.2000.01090.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
85 Marin MC, Jost CA, Brooks LA, Irwin MS, O’Nions J, Tidy JA, James N, McGregor JM, Harwood CA, Yulug IG. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet. 2000;25:47-54. [PMID: 10802655 DOI: 10.1038/75586] [Cited by in Crossref: 326] [Cited by in F6Publishing: 334] [Article Influence: 14.8] [Reference Citation Analysis]
86 Roth J, Koch P, Contente A, Dobbelstein M. Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain. Oncogene 2000;19:1834-42. [PMID: 10777217 DOI: 10.1038/sj.onc.1203500] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.1] [Reference Citation Analysis]
87 Alarcon-Vargas D, Fuchs SY, Deb S, Ronai Z. p73 transcriptional activity increases upon cooperation between its spliced forms. Oncogene 2000;19:831-5. [PMID: 10698502 DOI: 10.1038/sj.onc.1203311] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
88 Olumi AF. A critical analysis of the use of p53 as a marker for management of bladder cancer. Urol Clin North Am 2000;27:75-82, ix. [PMID: 10696247 DOI: 10.1016/s0094-0143(05)70236-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
89 Bagchi D, Balmoori J, Bagchi M, Ye X, Williams CB, Stohs SJ. Role of p53 tumor suppressor gene in the toxicity of TCDD, endrin, naphthalene, and chromium (vi) in liver and brain tissues of mice. Free Radical Biology and Medicine 2000;28:895-903. [DOI: 10.1016/s0891-5849(00)00173-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
90 Cerni C. Telomeres, telomerase, and myc. An update. Mutat Res. 2000;462:31-47. [PMID: 10648922 DOI: 10.1016/s1383-5742(99)00091-5] [Cited by in Crossref: 102] [Cited by in F6Publishing: 93] [Article Influence: 4.6] [Reference Citation Analysis]
91 Sheikh MS, Fornace AJ. Role of p53 family members in apoptosis. J Cell Physiol 2000;182:171-81. [DOI: 10.1002/(sici)1097-4652(200002)182:2<171::aid-jcp5>3.0.co;2-3] [Cited by in Crossref: 118] [Cited by in F6Publishing: 124] [Article Influence: 5.4] [Reference Citation Analysis]
92 Kane SA, Fleener CA, Zhang YS, Davis LJ, Musselman AL, Huang PS. Development of a Binding Assay for p53/HDM2 by Using Homogeneous Time-Resolved Fluorescence. Analytical Biochemistry 2000;278:29-38. [DOI: 10.1006/abio.1999.4413] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 1.7] [Reference Citation Analysis]
93 May P, May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene. 1999;18:7621-7636. [PMID: 10618702 DOI: 10.1038/sj.onc.1203285] [Cited by in Crossref: 397] [Cited by in F6Publishing: 400] [Article Influence: 18.0] [Reference Citation Analysis]
94 Wienzek S, Roth J, Dobbelstein M. E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53. J Virol 2000;74:193-202. [PMID: 10590106 DOI: 10.1128/jvi.74.1.193-202.2000] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 2.5] [Reference Citation Analysis]
95 Dasika GK, Lin SJ, Zhao S, Sung P, Tomkinson A, Lee EYP. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene 1999;18:7883-99. [DOI: 10.1038/sj.onc.1203283] [Cited by in Crossref: 270] [Cited by in F6Publishing: 279] [Article Influence: 12.3] [Reference Citation Analysis]
96 Kaelin WG Jr. Choosing anticancer drug targets in the postgenomic era. J Clin Invest 1999;104:1503-6. [PMID: 10587513 DOI: 10.1172/JCI8888] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
97 Mirkes PE, Wilson KL, Cornel LM. Teratogen-induced activation of ERK, JNK, and p38 MAP kinases in early postimplantation murine embryos. Teratology 2000;62:14-25. [DOI: 10.1002/1096-9926(200007)62:1<14::aid-tera6>3.0.co;2-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
98 Hara I, Miyake H, Hara S, Arakawa S, Kamidono S. Differential involvement of the Fas receptor/ligand system in p53-dependent apoptosis in human prostate cancer cells. Prostate 2000;45:341-9. [DOI: 10.1002/1097-0045(20001201)45:4<341::aid-pros9>3.0.co;2-m] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]